ICARES Medicus, Inc. (TPEX:6612)
70.20
+1.10 (1.59%)
At close: Mar 27, 2026
ICARES Medicus Revenue
In the year 2025, ICARES Medicus had annual revenue of 1.13B TWD with 31.54% growth. ICARES Medicus had revenue of 300.56M in the quarter ending December 31, 2025, with 17.00% growth.
Revenue
1.13B
Revenue Growth
+31.54%
P/S Ratio
2.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.13B | 271.19M | 31.54% |
| Dec 31, 2024 | 859.79M | 254.34M | 42.01% |
| Dec 31, 2023 | 605.45M | 93.60M | 18.29% |
| Dec 31, 2022 | 511.85M | 117.93M | 29.94% |
| Dec 31, 2021 | 393.92M | 31.25M | 8.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.25B |
| Formosa Optical Technology | 4.13B |
| St.Shine Optical | 4.12B |
| Pacific Hospital Supply | 2.41B |
| Nang Kuang Pharmaceutical | 2.16B |
| Bioteque | 2.14B |
| Bionime | 1.84B |
| Chi Sheng Pharma & Biotech | 1.38B |